6
Oct
2026

MUP

Exhibitor at CPHI Milan 2026 stand 18C59, Finished Dosage & Formulation
About Us

MUP established in 1984 to develop regional pharmaceutical market.​

MUP becomes leading international pharmaceutical company, generating revenue of around 2.4 Billion LE in 2018. We have a balanced business model for sustainability, covering branded generics and biosimilar that are well diversified by geography and product. We have operations in more than 40 countries across three continents, employing 2,357 people globally.​
We develop, manufacture and market a broad range of branded and non-branded generic pharmaceutical products across the ME, Africa, CIS and East Europe.

Our primary objective i...

Read more Show less
Categories
more categories Show less
  • Country/Region:
    Egypt
  • On CPHI since:
    2020
  • Employees:
    1000 - 4999
View company profile
Contact info
  • +20222737061
  • Website
  • 36 Dr. Mohamed Hasan Al Gamal, 6th District, Nasar City, 11471, Cairo, Egypt
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 18C59, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026

  • Insulinaegypt

    Product Insulinaegypt

    Active ingredient: Insulin human injection 
    Indication: Hypoglycemic Agent 

    Forms:    Vails & Cartilages

    Doses:   Insulinagypt N 100 IU
                   Insulinagypt R 100 IU ...
  • Davalindi Tablet

    Product Davalindi Tablet

    Active ingredient: 10 mg Cholecalciferol Concetrate (100.00 IU/g) equivalent to (1000 IU) cholecalciferol (vit. D3) 
    Indication: Vit. D3 supplement, treatment of rickets and osteoporosis 


    Forms: Tablet


    Pack Size: 100 tab 
  • Dexamethasone

    Product Dexamethasone

    Active ingredient: 8 mg Dexamethasone Phosphat / 2 ml Amp.        

    Indication: Systemic Corticosteroid 


    Forms: Ampoule
  • Levanic

    Product Levanic

    Active ingredient:  Levofluxacin

    Indication: Broad-Spectrum Antibiotic ( Quinolone Group )


    Forms: Levanic 500 mg Tablet
                Levanic 750 mg Tablet
  • Mobitil

    Product Mobitil

    Active ingredient: Meloxicam 

    Indication: Non steroidal Anti-inflammatory, analgesic 


    Forms: Tab, Amp and suppositories 


    Doses:  Mobitil  15 mg Supp, Mobitil  7.5mg Tab, Mobitil  15 mg Tab, Mobitil  15 mg Ampoule

Medical Union Pharmaceuticals Resources (1)